09:22 AM EDT, 08/06/2024 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) reported a Q2 net loss Tuesday of $0.55 per share, narrowing from a loss of $0.82 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.70 per share.

Total revenue for the quarter ended June 30 was $29.1 million, up from $19.2 million a year earlier.

Analysts surveyed by Capital IQ expected $28.8 million.